Manipal Health Q1 FY27 Revenue Surges 38% to ₹3,091 Crore; EBITDA at ₹749 Crore
Manipal Health Enterprises reported Q1 FY27 revenue of ₹3,091 crore, up 38% YoY, and EBITDA of ₹749 crore, up 26% YoY. Growth was volume-led, with inpatient volumes up 39% and OP volumes up 26%. Digital revenue contributed 23% of total revenue. Investments in technology and clinical advancements were highlighted. Sahyadri Hospitals saw 13% revenue growth.
The announcement details significant financial growth, strategic investments in technology and expansion, and positive operational improvements across the network, including the integration of Sahyadri Hospitals. These factors are material to the company's performance and future prospects.
The company reported strong year-on-year growth in revenue and EBITDA, driven by increased patient volumes and contributions from its Centres of Excellence. Investments in technology and significant clinical achievements further strengthen the positive outlook.
Manipal Health Enterprises Limited reported a robust Q1 FY27 performance, with revenue growing by over 38% year-on-year to ₹3,091 crore. Network EBITDA stood at ₹749 crore, a growth of over 26% over the previous year. Excluding a one-off gain from last year, the growth is over 30%. The company's growth was volume-led, with inpatient volumes increasing by 39% and outpatient volumes by 26% compared to Q1 FY26. Average occupancy across the network was 65%, a 290 basis points increase. Digital revenue contributed ₹710 crore, representing 23% of the total revenue.
The company's Centres of Excellence, including Cardiology, Oncology, and Neurology, continued to be key growth drivers, contributing 65% of Q1 FY27 revenue, with IP revenues in these specialties growing by 45%. Investments in advanced medical equipment, such as a linear accelerator and PET-CT at the Nashik hospital, and AI-assisted neuro biplane cath lab in Kolkata, were highlighted. Clinical achievements included the world's first robotic pancreatic surgery on an infant and the state's first emergency living-donor liver transplant.
Sahyadri Hospitals reported revenue of ₹332 crore in Q1 FY27, a growth of over 13% year-on-year, with EBITDA at ₹58 crore, up 19% year-on-year. Integration efforts are progressing as planned, with enhancements to clinical programs, talent addition, and infrastructure upgrades contributing to performance. The company also commissioned a brownfield capacity addition of 103 beds at its Nashik hospital and launched its 50th hospital in Electronic City, Bangalore, in July. Additionally, Manipal Health Enterprises announced a transaction to acquire Kinder Hospital in Whitefield, Bangalore.
Management indicated that the integration of Sahyadri Hospitals is expected to be a 16-18 month process, with a focus on improving profitability through clinical enhancement and operating efficiencies. The company highlighted its strategy of volume-led growth and improving complexity of cases, rather than price-led growth. Capex for the current year is expected to be around ₹2,000 crore, with a significant portion spent in Q1 itself.
A plain-language summary of a public exchange filing by Manipal Health Enterprises Limited. Read the original for the full detail.